• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗菌化疗中口服治疗替代胃肠外治疗的经济影响。

Economic implications of oral treatment replacing parenteral therapy in antimicrobial chemotherapy.

作者信息

Leigh D A

机构信息

Department of Microbiology, Wycombe General Hospital, Bucks, England.

出版信息

Chemioterapia. 1988 Dec;7(6):400-5.

PMID:3219753
Abstract

The cost of antimicrobial chemotherapy is a major part of the total hospital pharmacy cost. Parenteral administration is considerably more expensive than oral and until recently was the only available therapy for nosocomial and resistant bacterial infections. Apart from the cost of the antimicrobial agent itself, many other factors such as the infusion sets, catheters and cannulae, monitoring of blood to avoid toxicity and other laboratory investigations will influence the costs. The introduction of ciprofloxacin, a new quinolone, with a wide range of bacterial activity which can be prescribed orally, will have economic advantages in the treatment of hospital infections.

摘要

抗微生物化疗的费用是医院药房总费用的主要组成部分。肠胃外给药比口服给药昂贵得多,直到最近,它还是治疗医院感染和耐药细菌感染的唯一可用疗法。除了抗微生物药物本身的成本外,许多其他因素,如输液装置、导管和套管、监测血液以避免毒性以及其他实验室检查,都会影响成本。新喹诺酮类药物环丙沙星具有广泛的细菌活性,可口服给药,它的引入将在医院感染治疗中具有经济优势。

相似文献

1
Economic implications of oral treatment replacing parenteral therapy in antimicrobial chemotherapy.抗菌化疗中口服治疗替代胃肠外治疗的经济影响。
Chemioterapia. 1988 Dec;7(6):400-5.
2
Focus on oral ciprofloxacin; clinical and economic considerations.关注口服环丙沙星:临床与经济考量
Hosp Pharm. 1989 Oct;24(10):814-20, 823-6, 842.
3
Impact of nosocomial infections on hospital costs.医院感染对医院成本的影响。
Hosp Formul. 1993 Jan;28 Suppl 1:51-4.
4
Economic impact of oral ciprofloxacin. A pharmacist's perspective.
Am J Med. 1987 Apr 27;82(4A):387-90.
5
Transitional (intravenous to oral) antibiotic therapy.
J Med Liban. 2000 Jul-Aug;48(4):233-40.
6
Pharmacoeconomic comparison of sequential IV/oral ciprofloxacin versus ceftazidime in the treatment of nosocomial pneumonia.序贯静脉注射/口服环丙沙星与头孢他啶治疗医院获得性肺炎的药物经济学比较
Can J Hosp Pharm. 1995 Oct;48(5):276-83.
7
Economic impact of streamlining antibiotic administration.简化抗生素管理的经济影响。
Am J Med. 1987 Apr 27;82(4A):391-4.
8
Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.环丙沙星:一种用于治疗革兰氏阴性病原体感染的口服喹诺酮类药物。抗菌药物委员会。加拿大传染病协会。
CMAJ. 1994 Mar 1;150(5):669-76.
9
Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey.基于法国患病率调查的医院感染抗菌治疗费用
J Hosp Infect. 1999 Aug;42(4):303-12. doi: 10.1053/jhin.1998.0612.
10
Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity.住院患者对抗菌药物的不必要使用:当前的滥用模式,重点关注抗厌氧活性谱。
Arch Intern Med. 2003 Apr 28;163(8):972-8. doi: 10.1001/archinte.163.8.972.